News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NewLink Genetics Appoints Eugene P. Kennedy, M.D., As Vice President For Clinical And Medical Affairs


2/26/2014 12:01:45 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AMES, IA--(Marketwired - Feb 26, 2014) - NewLink Genetics Corporation (NASDAQ: NLNK), a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutics to improve treatment options for patients with cancer, today announced the appointment of Eugene P. Kennedy, M.D., FACS, as Vice President for Clinical and Medical Affairs. Dr. Kennedy will be responsible for clinical operations related to NewLink's HyperAcute® and IDO (indoleamine-(2,3)-dioxygenase) pathway product candidates as well as supporting commercial development strategies.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES